Last checked at 3 Sep 2012 17:36
For immediate release | 3 September 2012 |
Futura Medical plc
("Futura" or "the Company")
TR-1: Notification of major interest in shares
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES |
| |||||||||||||||||
1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: | Futura Medical |
| ||||||||||||||||
2. Reason for the notification (please tick the appropriate box or boxes) |
| |||||||||||||||||
An acquisition or disposal of voting rights |
| |||||||||||||||||
An acquisition or disposal of financial instruments which may result in the acquisition of shares already issued to which voting rights are attached |
| |||||||||||||||||
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments |
| |||||||||||||||||
An event changing the breakdown of voting rights |
| |||||||||||||||||
Other (please specify): Transfer into Nominees | x |
| ||||||||||||||||
3. Full name of person(s) subject to the notification obligation: | Investec Wealth & Investment Limited |
| ||||||||||||||||
4. Full name of shareholder(s) (if different from 3.): |
| |||||||||||||||||
5. Date of the transaction and date on which the threshold is crossed or reached if different: | 28th August 2012 |
| ||||||||||||||||
6. Date on which issuer notified: | 3rd September 2012 |
| ||||||||||||||||
7. Threshold(s) that is/are crossed: | 4% |
| ||||||||||||||||
| ||||||||||||||||||
8.Notified details: Nominee holdings | ||||||||||||||||||
A: Voting rights attached to shares | ||||||||||||||||||
Class/type of Shares
if possible using the ISIN CODE | Situation previous to the triggering transaction | Resulting situation after the triggering transaction | ||||||||||||||||
| Number of Shares | Number of Voting Rights | Number of shares | Number of voting rights | % of voting rights | ||||||||||||||
| Direct | Direct | Indirect | Direct | Indirect | ||||||||||||||
3327847 | 1,863,240 | 1,863,240 | 3,018,485 | 4.09% | ||||||||||||||
B: Financial Instruments | ||||||||||||||||||
Resulting situation after the triggering transaction | ||||||||||||||||||
Type of financial instrument | Expiration date | Exercise/ Conversion Period/ Date | Number of voting rights that may be acquired if the instrument is exercised/ converted | % of voting rights | ||||||||||||||
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments | ||||||||||||||||||
Resulting situation after the triggering transaction | ||||||||||||||||||
Type of financial instrument | Exercise price | Expiration Date | Exercise/ Conversion period | Number of voting rights instrument refers to | % of voting rights | |||||||||||||
Nominal | Delta | |||||||||||||||||
Total (A+B+C) | ||||||||||||||||||
Number of voting rights | Percentage of voting rights | |||||||||||||||||
3,018,485 | 4.09% | |||||||||||||||||
Proxy Voting: | ||||||||||||||||||
10. Name of the proxy holder: | N/A | |||||||||||||||||
11. Number of voting rights proxy holder will cease to hold: | N/A | |||||||||||||||||
12. Date on which proxy holder will cease to hold voting rights: | N/A | |||||||||||||||||
13. Additional information: | ||||||||||||||||||
14. Contact name: | Phil Beardwell Chartered FCSI Senior Compliance Manager | |||||||||||||||||
15. Contact telephone number: | 020 7597 1356 | |||||||||||||||||